Cambridge Cognition (LON:COG) Trading Down 6.5% – Here’s Why

Cambridge Cognition Holdings Plc (LON:COG) fell 6.5% during mid-day trading on Friday . The stock traded as low as GBX 34 ($0.45) and last traded at GBX 34.60 ($0.46). 77,232 shares changed hands during mid-day trading, an increase of 119% from the average session volume of 35,308 shares. The stock had previously closed at GBX 37 ($0.49).

Cambridge Cognition Stock Up 0.6%

The company’s fifty day simple moving average is GBX 32.37 and its 200-day simple moving average is GBX 34.25. The company has a debt-to-equity ratio of 92.53, a current ratio of 0.65 and a quick ratio of 0.96. The firm has a market capitalization of £16.15 million, a PE ratio of -913.16 and a beta of 0.72.

Cambridge Cognition (LON:COG) last announced its earnings results on Tuesday, September 2nd. The company reported GBX (2.40) earnings per share for the quarter. Cambridge Cognition had a negative return on equity of 68.83% and a negative net margin of 10.07%. On average, analysts forecast that Cambridge Cognition Holdings Plc will post 1.0293539 EPS for the current year.

Cambridge Cognition Company Profile

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.